Skip to main content
NCBI home page
American Journal of Public Health logoLink to American Journal of Public Health
. 1989 Aug;79(8):1006–1010. doi: 10.2105/ajph.79.8.1006

Psychoactive drug use in a general population sample, Sweden: correlates with perceived health, psychiatric diagnoses, and mortality in an automated record-linkage study.

C Allgulander 1
PMCID: PMC1349896  PMID: 2751014

Abstract

Three person-based computer files were linked to provide a data-set of a random sample of 32,679 Swedes, drawn for interviews regarding perceived health, socioeconomic conditions, and psychoactive drug use. All diagnoses from inpatient psychiatric care in the sample during a 15-year period and the causes of death after the sampling point were combined with the interview responses. Among those admitted for inpatient psychiatric care, substance abuse was an infrequent diagnosis; the majority of schizophrenics and of those with an affective disorder appeared not to medicate regularly; survey non-responders had higher rates of mental disorders than responders. Drug use correlated with both subjective and objective measures of mental ill health. The rate of prescription drug abuse was low. Automated record-linkage is a feasible method to generate hypotheses about mental health in the general population.

Full text

PDF
1006

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allgulander C. Bruk och missbruk av bensodiazepiner--en psykiatrisk och epidemiologisk översikt. Lakartidningen. 1987 Oct 7;84(41):3274–3276. [PubMed] [Google Scholar]
  2. Boethius G., Westerholm B. Is the use of hypnotics, sedatives and minor tranquilizers really a major health problem? Acta Med Scand. 1976;199(6):507–512. doi: 10.1111/j.0954-6820.1976.tb06771.x. [DOI] [PubMed] [Google Scholar]
  3. Boethius G., Westerholm B. Purchases of hypnotics, sedatives and minor tranquillizers among 2,566 individuals in the county of Jämtland, Sweden. A 6-year follow-up. Acta Psychiatr Scand. 1977 Aug;56(2):147–159. doi: 10.1111/j.1600-0447.1977.tb06673.x. [DOI] [PubMed] [Google Scholar]
  4. Crutchfield R. D., Gove W. R. Determinants of drug use: a test of the coping hypothesis. Soc Sci Med. 1984;18(6):503–509. doi: 10.1016/0277-9536(84)90008-x. [DOI] [PubMed] [Google Scholar]
  5. Fleiss J. L., Williams J. B., Dubro A. F. The logistic regression analysis of psychiatric data. J Psychiatr Res. 1986;20(3):195–209. doi: 10.1016/0022-3956(86)90003-8. [DOI] [PubMed] [Google Scholar]
  6. Haglund B. J., Isacsson S. O., Rydén L., Råstam L. Health profile of Skaraborg County 1977. A Swedish rural cross-sectional study. Scand J Prim Health Care. 1983;1(3-4):102–113. doi: 10.3109/02813438309038477. [DOI] [PubMed] [Google Scholar]
  7. Helgason T. Prevalence and incidence of mental disorders estimated by a health questionnaire and a psychiatric case register. Acta Psychiatr Scand. 1978 Sep;58(3):256–266. doi: 10.1111/j.1600-0447.1978.tb06937.x. [DOI] [PubMed] [Google Scholar]
  8. Marinier R. L., Pihl R. O., Wilford C., Lapp J. E. Psychotropic drug use by women: demographic, lifestyle, and personality correlates. Drug Intell Clin Pharm. 1985 Jan;19(1):40–45. doi: 10.1177/106002808501900111. [DOI] [PubMed] [Google Scholar]
  9. Mellinger G. D., Balter M. B., Uhlenhuth E. H. Prevalence and correlates of the long-term regular use of anxiolytics. JAMA. 1984 Jan 20;251(3):375–379. [PubMed] [Google Scholar]
  10. Murphy J. M., Olivier D. C., Sobol A. M., Monson R. R., Leighton A. H. Diagnosis and outcome: depression and anxiety in a general population. Psychol Med. 1986 Feb;16(1):117–126. doi: 10.1017/s0033291700057809. [DOI] [PubMed] [Google Scholar]
  11. Murray J., Williams P., Clare A. Health and social characteristics of long-term psychotropic drug takers. Soc Sci Med. 1982;16(18):1595–1598. doi: 10.1016/0277-9536(82)90289-1. [DOI] [PubMed] [Google Scholar]
  12. Riska E., Klaukka T. Use of psychotropic drugs in Finland. Soc Sci Med. 1984;19(9):983–989. doi: 10.1016/0277-9536(84)90329-0. [DOI] [PubMed] [Google Scholar]
  13. Robins L. N., Helzer J. E., Weissman M. M., Orvaschel H., Gruenberg E., Burke J. D., Jr, Regier D. A. Lifetime prevalence of specific psychiatric disorders in three sites. Arch Gen Psychiatry. 1984 Oct;41(10):949–958. doi: 10.1001/archpsyc.1984.01790210031005. [DOI] [PubMed] [Google Scholar]
  14. Siciliani O., Bellantuono C., Williams P., Tansella M. Self-reported use of psychotropic drugs and alcohol abuse in South-Verona. Psychol Med. 1985 Nov;15(4):821–826. doi: 10.1017/s0033291700005055. [DOI] [PubMed] [Google Scholar]
  15. Uhlenhuth E. H., Balter M. B., Mellinger G. D., Cisin I. H., Clinthorne J. Symptom checklist syndromes in the general population. Correlations with psychotherapeutic drug use. Arch Gen Psychiatry. 1983 Nov;40(11):1167–1173. doi: 10.1001/archpsyc.1983.01790100013001. [DOI] [PubMed] [Google Scholar]
  16. Ware J. E., Jr, Manning W. G., Jr, Duan N., Wells K. B., Newhouse J. P. Health status and the use of outpatient mental health services. Am Psychol. 1984 Oct;39(10):1090–1100. doi: 10.1037//0003-066x.39.10.1090. [DOI] [PubMed] [Google Scholar]
  17. Wells K. B., Kamberg C., Brook R., Camp P., Rogers W. Health status, sociodemographic factors, and the use of prescribed psychotropic drugs. Med Care. 1985 Nov;23(11):1295–1306. doi: 10.1097/00005650-198511000-00008. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES